Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.0760
-0.0140 (-15.56%)
At close: Jan 29, 2026
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of $13.39 million as of February 12, 2026. Its market cap has decreased by -38.67% in one year.
Market Cap
13.39M
Enterprise Value
17.54M
Revenue
1.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 47.65M to 13.39M, a decrease of -71.90%. That is a compound annual growth rate of -16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 13.93M | 8.17% |
| Dec 31, 2025 | 12.87M | -34.45% |
| Dec 31, 2024 | 19.64M | 49.77% |
| Dec 29, 2023 | 13.11M | -68.92% |
| Dec 31, 2021 | 42.20M | 111.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 22.08M |
| Oncotelic Therapeutics | 21.62M |
| Zenith Capital | 19.17M |
| Zeo ScientifiX | 18.28M |
| Provectus Biopharmaceuticals | 18.07M |
| TRON Group | 14.61M |
| HOOKIPA Pharma | 13.12M |
| Inhibitor Therapeutics | 10.01M |